On January and June, 2002 four Cord Blood Transplantations were implemented at HCMC Blood Transfusion Hematology Center with ALL, AML, CML and (Thalassemia, where a relation and three unrelation, Results: ANC>0.5x109 L/L: 21 days (relation) and 45 days (unrelation). Platelet count of >50x109 L/L: 27 days (relation) and 60 days (unrelation).
Cord Blood Stem Cell Transplantation ; Fetal Blood

From Apr. 2001 to Nov. 2003, at HCM City Blood Transfusion and Hematology Hospital, study was performed to evaluate preliminarily the quality of stem cell preparation producted from umbilical blood cells after processed with CD34+ cells count , flown cytometry and with stem cell culture on methylcellulose medium. Results showed :the average CD34 stem cell count after processing in umbilical cord blood bag 1,94+/-1,05x1000 000 In 1ml cell culture : BFU- E:0,25x 1000 /ml, CFU-GM:6,75x 1000 /ml, CFU-Mix:8,55x1000 /ml
Cord Blood Stem Cell Transplantation ; Blood ; Cells

In 2002-2003 year period at HCM City Blood Transfusion and Hematology 8 cases of umbilical cord blood transplantation were performed.including 2 cases of lymphoid acute leukemia, 3 cases of myeloid acute leukemia, 3 cases of beta thalassemia. Among them, there were a case of HLA- identical blood and 7 cases of HLA-dismatched blood. After 36 months, 61,90% of cases were recovered survivals and after 24 months 71,43%
Stem Cell Transplantation ; Epidemiology ; Vietnam ; Cord Blood Stem Cell Transplantation

No abstract available.
Cord Blood Stem Cell Transplantation* ; Fetal Blood* ; Umbilical Cord*

From Jan.2002 to Nov.2003, umbilical cord blood was collected, screened and processed at HCM City Blood Transfusion and Hematology Hospital for preparing to transplant. The Tokyo Umbilical Cord Blood Bank protocol of collecting, screening, processing and freezing were abided strictly, therefore, the obtained results were consistent with international literature. A stable procedure was established for the proper processus of UCB collection, screening and processing to meet the need of management of hereditary and malignant pathologies in Viet Nam
Fetal Blood ; Blood ; Cord Blood Stem Cell Transplantation

Blood Banks ; Cord Blood Stem Cell Transplantation ; Fetal Blood ; Humans

No abstract available.
Cord Blood Stem Cell Transplantation* ; Fetal Blood* ; Humans ; Leukemia* ; Siblings*

China ; Cord Blood Stem Cell Transplantation ; Fetal Blood ; cytology ; Hematopoietic Stem Cell Transplantation ; Humans

Cord Blood Stem Cell Transplantation ; Female ; Humans ; Infant ; Osteopetrosis ; therapy

This paper summarizes the current literature on the potential therapeutic role of stem cell transplantation for kidney injury and repair and focuses on the choice of types of stem cells, the method of transplantation, and the mechanisms of stem cell homing to injured renal tissues and its protective effects. The application of umbilical cord mesenchymal stem cells (UC-MSCs) shows wide prospects, but the approach and optimal dose of cell transplantation are under intensive investigation. Signals that regulate stem cell homing to injured renal tissues may be related to chemokines or factors released in the target site. Several studies have pointed out that paracrine and endocrine of stem cells are the most likely mechanism of action in the injured nephron. Many questions remain unanswered but stem cell-based therapy is a promising new strategy for acute and chronic kidney diseases.
Animals ; Cord Blood Stem Cell Transplantation ; Humans ; Kidney Diseases ; therapy ; Mesenchymal Stem Cell Transplantation ; Stem Cell Transplantation ; methods